Protective effects of oyster protein hydrolysates on alcohol-induced liver disease (ALD) in mice: based on the mechanism of anti-oxidative metabolism
- 1 July 2022
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 13 (16) , 8411-8424
Abstract
Many bioactivities of hydrolysates from oyster (Crassostrea gigas) muscle have been reported, while there is no knowledge about their protective effects on alcohol-induced liver disease (ALD). In the present study, the anti-oxidative activities in vitro and molecular weight distribution of oyster protein hydrolysates (OPH) were detected and the OPH released by alcalase (AOPH) was used to treat C57BL/6 mice. C57BL/6 mice were treated with a Lindros control diet to establish an ethanol-exposed model. The content of small-weight components (in vitro with higher reducing power and ferric reducing antioxidant power (FRAP), and those capacities could be maintained at a high level after simulated gastrointestinal digestion. Compared to the model mice, oral administration (4 weeks) of AOPH at 800 mg per kg body weight could lead to a decline in T-AOC, GSH-PX, and ADH in the liver. The hepatocellular lesions were effectively relieved and impaired liver tissue development was successfully inhibited. A total of 834 genes and 54 proteins showed differential expression in the AOPH group and the oxidative metabolic pathways of ethanol such as oxidative phosphorylation, glutathione metabolism, peroxisomes, the PPAR signaling pathway and drug metabolism–cytochrome P450 play a preeminent role in ALD according to the results of transcriptomics and proteomics. The beneficial effects of AOPH were available in the improvement of ALD. These results revealed that AOPH intervention ameliorated ALD by affecting oxidative metabolism and highlighting AOPH's potential application as a functional food.Keywords
Funding Information
- Ministry of Science and Technology of the People's Republic of China (2017YFD0400200)
- China Agricultural Research System (CARS-45)
This publication has 53 references indexed in Scilit:
- In Vitro Antioxidant Activity and In Vivo Anti-fatigue Effects of Oyster (Ostrea plicatula Gmelin) Peptides Prepared Using Neutral ProteinaseFood Science and Technology Research, 2013
- Alcoholic Liver Disease: Pathogenesis and New Therapeutic TargetsGastroenterology, 2011
- Integrated hepatic transcriptome and proteome analysis of mice with high-fat diet-induced nonalcoholic fatty liver diseaseThe Journal of Nutritional Biochemistry, 2011
- Protective effect of an antioxidative peptide purified from gastrointestinal digests of oyster, Crassostrea gigas against free radical induced DNA damageBioresource Technology, 2008
- Emerging Role of Nrf2 in Protecting Against Hepatic and Gastrointestinal DiseaseToxicologic Pathology, 2007
- Alcohol and lipid metabolismJournal of Gastroenterology and Hepatology, 2006
- ERK/MAPK regulates the Kv4.2 potassium channel by direct phosphorylation of the pore-forming subunitAmerican Journal of Physiology-Cell Physiology, 2006
- Do alcohol-metabolizing enzyme gene polymorphisms increase the risk of alcoholism and alcoholic liver disease?Hepatology, 2006
- Genetic Factors in Alcohol Metabolism and AlcoholismSeminars in Liver Disease, 1993
- Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptorsCell, 1992